ATE295157T1 - Mittel zur transdermalen verabreichung von arzneistoffen - Google Patents

Mittel zur transdermalen verabreichung von arzneistoffen

Info

Publication number
ATE295157T1
ATE295157T1 AT97901642T AT97901642T ATE295157T1 AT E295157 T1 ATE295157 T1 AT E295157T1 AT 97901642 T AT97901642 T AT 97901642T AT 97901642 T AT97901642 T AT 97901642T AT E295157 T1 ATE295157 T1 AT E295157T1
Authority
AT
Austria
Prior art keywords
medicinal
agent
drug
transdermal administration
medicine
Prior art date
Application number
AT97901642T
Other languages
English (en)
Inventor
Risto Jaernstroem
Jouni Hirvonen
Original Assignee
Novagent Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI960435A external-priority patent/FI960435L/fi
Priority claimed from FI962450A external-priority patent/FI962450A0/fi
Application filed by Novagent Oy filed Critical Novagent Oy
Application granted granted Critical
Publication of ATE295157T1 publication Critical patent/ATE295157T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97901642T 1996-01-30 1997-01-27 Mittel zur transdermalen verabreichung von arzneistoffen ATE295157T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI960435A FI960435L (fi) 1996-01-30 1996-01-30 Lääkkeiden transdermaalisen antotapaan tarkoitettu koostumus
FI962450A FI962450A0 (fi) 1996-06-12 1996-06-12 Farmaceutisk sammansaettning och foerfarande foer dosering av laekemedel
PCT/FI1997/000039 WO1997027844A1 (en) 1996-01-30 1997-01-27 Composition for transdermal delivery of drugs

Publications (1)

Publication Number Publication Date
ATE295157T1 true ATE295157T1 (de) 2005-05-15

Family

ID=26160098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901642T ATE295157T1 (de) 1996-01-30 1997-01-27 Mittel zur transdermalen verabreichung von arzneistoffen

Country Status (7)

Country Link
US (1) US6254883B1 (de)
EP (1) EP0942716B1 (de)
JP (1) JP2000504002A (de)
AT (1) ATE295157T1 (de)
CA (1) CA2242753A1 (de)
DE (1) DE69733268T2 (de)
WO (1) WO1997027844A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107372B (fi) * 1999-04-29 2001-07-31 Novagent Oy Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen
BR0307667A (pt) * 2002-02-13 2006-04-11 Beek Global L L C Van composições e métodos para aumentar a produção de leite em animais
WO2007078007A1 (ja) * 2006-01-06 2007-07-12 Japan Science And Technology Agency カーボンナノホーン構造体並びにその内在有機物の放出を制御可能とする組成物とその方法
JP5558096B2 (ja) 2007-03-01 2014-07-23 株式会社日本触媒 吸水性樹脂を主成分とする粒子状吸水剤
US20100120940A1 (en) 2007-04-05 2010-05-13 Nippon Shokubai Co., Ltd. Particulate water-absorbing agent having water-absorbing resin as main component
KR101627597B1 (ko) * 2010-07-30 2016-06-08 이엠디 밀리포어 코포레이션 부직포 층
FI125075B (fi) 2012-08-13 2015-05-29 Novagent Oy Vaikuttavan aineen iontoforeettinen annostelujärjestelmä
AU2014252652A1 (en) * 2013-04-10 2015-11-26 Glycobiosciences, Inc. Topical nutraceutical composition
CN106794389A (zh) 2014-09-02 2017-05-31 Emd密理博公司 具有纳米原纤化表面特征的高表面积纤维介质
US9669012B2 (en) 2014-10-30 2017-06-06 Textile-Based Delivery, Inc. Delivery systems
CA2966515C (en) 2014-12-08 2021-04-27 Emd Millipore Corporation Mixed bed ion exchange adsorber
WO2021262986A1 (en) * 2020-06-24 2021-12-30 Anika Therapeutics, Inc. Composite medical textile with non-resorbable fibers and bioresorbable hyaluronan-based fibers
US12514756B1 (en) 2024-10-08 2026-01-06 Covidien Lp Dermal patch and systems, kits, and methods associated therewith

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE603705C (de) 1931-06-18 1934-10-08 Desider Deutsch Dr Elektrode zur Einfuehrung von Heilmitteln in den Koerper mittels Iontophorese
FI52816C (fi) 1974-03-28 1983-05-10 Exel Oy Trissa foer skidstav
US4032452A (en) 1975-11-13 1977-06-28 Sybron Corporation Electrically regenerated ion exchange system
US4585652A (en) 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4731049A (en) 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5162042A (en) 1988-07-05 1992-11-10 Alza Corporation Electrotransport transdermal system
US5098417A (en) 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US5147297A (en) 1990-05-07 1992-09-15 Alza Corporation Iontophoretic delivery device
IE920763A1 (en) 1991-03-11 1992-09-23 Alza Corp Iontophoretic delivery device and method of making same
AU5354994A (en) 1992-10-15 1994-05-09 Alza Corporation Delayed onset transdermal delivery device
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
JP2001520527A (ja) 1994-09-30 2001-10-30 ベクトン・ディッキンソン・アンド・カンパニー 使い捨てパッチと再使用可能で取り外し可能なコントローラーとを包含するイオン導入式薬物投与系
US5894021A (en) 1994-09-30 1999-04-13 Kabushiki Kaisya Advance Iontophoretic transdermal drug-delivery interface and skin treatment agent and treatment method using the same

Also Published As

Publication number Publication date
US6254883B1 (en) 2001-07-03
DE69733268T2 (de) 2006-01-19
DE69733268D1 (de) 2005-06-16
WO1997027844A1 (en) 1997-08-07
CA2242753A1 (en) 1997-08-07
EP0942716A1 (de) 1999-09-22
JP2000504002A (ja) 2000-04-04
EP0942716B1 (de) 2005-05-11

Similar Documents

Publication Publication Date Title
FI943430A7 (fi) Lääkkeenantojärjestelmä entsyymeillä ja valolle aktivoitavien lääkkeiden samanaikaiseksi vapauttamiseksi
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
AU7465087A (en) Controlled release bioerodible drug delivery system
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
DE69506007D1 (de) Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen
BG103552A (bg) Терапевтични средства
ATE116131T1 (de) Mittel zur nichsystemischen verabreichung von sedativa und analgetika.
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
NO872381L (no) Fremgangsmaate for fremstilling av langsomt frigivende preparater.
ES2007100A6 (es) Procedimiento para la obtencion de un sistema terapeutico oral a base de carbamazepina.
NO920832D0 (no) Faststoffmatrikssystem for transdermal medikamentavlevering
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
TR200000149T2 (tr) Serebral nörovasküler bozuklukların, müsküler baş ağrılarının önlenmesine yönelik kompozisyonlar
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
HUP9901890A2 (hu) Gyógyszer és eljárás szervezet gyógyszeres kezelésére
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
DE59608150D1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
DK1152763T3 (da) Anvendelse af desozypeganin til behandling af stofafhængighed
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
DE69727222D1 (de) Zusammensetzung und system zur iontophoretischen transdermalen abgabe von medikamenten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties